Request a Demo
Press, Press Release

The Association of German Cardiologists BNK Lists the Telemonitoring System Offered by Implicity and HCSG

/

The Association of German Cardiologists BNK Lists the Telemonitoring System Offered by Implicity and HCSG The Association of German Cardiologists BNK Service GmbH lists the telemonitoring system “hedy” from HCSG and IMPLICITY to cardiologists in private practice. As a unique cloud-based and vendor-independent platform for heart failure telemonitoring, hedy enables telemonitoring with external devices and implants from all major manufacturers via a common TMZ portal. This listing by BNK Service GmbH was made after intensive testing and based on positive references from cardiologists who are already using the hedy telemonitoring system today. Since the beginning of 2022, telemonitoring patients with heart failure (cardiac insufficiency) has been part of the outpatient service offered by the statutory health insurance funds. “We want telemonitoring for heart failure to reach all patients eligible for this innovative treatment method as quickly as possible. That is why we are pleased to have gained HCSG and IMPLICITY, two very capable partners for cardiology practices.”Susanne Oldenburg of BNK Service GmbH. To implement telemonitoring, a cardiology-led telemedicine center (TMZ) must use either external devices (scales, ECG and blood pressure monitors, and patient apps) or data from implants (special pacemakers and defibrillators). For this purpose, hedy offers a unique cloud-based platform for telemonitoring of heart failure, via which the data of implants from all major manufacturers and external devices can be displayed and evaluated automatically and independently of the manufacturer via a common TMZ portal. Hedy requires no IT installation or maintenance of IT systems in the physicianˈs office. Physicians can access HCSGˈs certified tele-nurse center, relieving their practices of routine tasks. “Cardiologists need the support of competent service providers to operate a telemedicine center. The practices we interviewed reported their excellent experience, reliable service, and HCSGˈs profound expertise in monitoring with external devices. Implants from all major manufacturers can be connected via the IMPLICITY system. This provides cardiologists with a common portal for all forms of telemonitoring. We see this as a great advantage for patient care.”Simon Glück, Managing Director of BNK Service GmbH. BNK Service GmbH has intensively tested the technology and service offering around hedy. The consistently positive feedback from practices that operate a TMZ with hedy and have already gained sound experience in its use has convinced BNK Service GmbH. To date, around 350 physicians are using hedy telemonitoring. Users of hedy can be found in individual practices as well as in sizeable professional practice groups (joint practices) or medical care centers (MVZ). “We want to ensure that all heart failure patients receive optimal care. Even those who find it difficult to get to the doctor because they live in rural areas or, in particular, the elderly patients. With hedy and the companies HCSG and IMPLICITY at our side, the start for this is quite easy, and we canbenefit from their years of experience. The direct accessibility and service canˈt be beaten.”Dr. Placke specialist practice for cardiological primary and specialty care in Rostock, Germany. “We had already preferred the hedy telemonitoring system based on recommendations from colleagues. The presentation of experienced users of the hedy solution for external devices and implants in the BNK webinars strengthened our decision. And we are starting with hedy in the new year.”Dr. med. Gabelmann and Prof. Pottgießer, Cardiology Dreisamtal/Kirchzarten Background:Since the beginning of 2022, telemonitoring patients with heart failure (cardiac insufficiency) has been part of the outpatient service offered by the statutory health insurance funds. Telemonitoring can be prescribed to patients with heart failure (NYHA II – III and EF < 40) if they have been treated in the hospital in the last 12 months or if they wear a suitable implant.To implement telemonitoring, a telemedicine center (TMZ) must use either external devices (scales, ECG and blood pressure monitors, and patient apps) or implants (special pacemakers and defibrillators). Hedy (https://hedy.de) refers to a system for telemedicine care of patients with heart failure. The solution is aimed at cardiologists who want to operate their own TMZ. Hedy is a registered trademark of Health Care Systems GmbH. Cooperation partners:HCSG specializes in telemonitoring with external devices, while IMPLICITY processes the data of implants from all major manufacturers for cardiologists. With the complete solution from HCSG and IMPLICITY, consisting of devices, software, service, and consulting, cardiologists can immediately set up their own TMZ (https://www.IMPLICITY.com/landing-page/partnership-IMPLICITY-x-hcsg/). BNK Service GmbH (https://www.bnk-service.de/) is the subsidiary of the Bundesverband Niedergelassener Kardiologen (BNK) e.V., which represents more than 90 percent of the practicing cardiologists in Germany. BNK Service supports approximately 1,200 cardiologists in their daily practice. In addition, as a specialized service provider for the entire cardiology field, it networks all the players involved in care. As a central interface, BNK Service GmbH develops and manages comprehensive care concepts, conducts scientific surveys on care research, and thus provides a realistic picture of cardiological care in Germany.Your contact: Simon GlückPhone: +49 89 41 42 40 8-14, Email: simon.glueck@bnk-service.de IMPLICITY (https://implicity.com) is a digital medical technology company that provides healthcare providers with a universal telemonitoring platform that aggregates and uniformly displays implantable cardiac implant data from all major manufacturers. In addition, IMPLICITY develops AI and knowledge-based algorithms to empower physicians and enable them to predict patient health status. IMPLICITY serves over 80,000 patients in more than 150 medical facilities in Europe and the US.Your contact: Karsten HagemannPhone: +33 680 10 50 65, Email: karsten.hagemann@implicity.com Health Care Systems GmbH (https://hcsg.de) is a leading provider of solutions for digital precision medicine. The HCSG team has more than 16 years of experience in telemedicine care for patients with heart failure. Today, HCSG serves patients throughout Germany and Switzerland with more than 60 employees at three locations. HCSG has developed the hedy Telemonitoring Program (https://hedy.de) specifically for use in telemedicine centers. The system is particularly easy to use because it is tailored to the needs of older people with severe chronic illnesses. Specialized nurses staff HCSG’s service center with special training in telephone care for people with heart failure. Health data is processed in a high-security data center in Germany.Your contact: Christian KlossPhone: +49 89

Editorial, Press

Remote Monitoring Device Clinics- Managing Through the Chaos

/

Remote Monitoring Device Clinics- Managing Through the Chaos Those who have dedicated their lives to cardiology are experiencing burnout at a record pace. This is especially true for physicians and medical teams remotely monitoring patients with CIEDs (Cardiac Implantable Electronic Devices). The growing number of patients involved in remote monitoring (RM) programs has led to increased data that cardiac clinics need to review and manage. The issue will only get worse in the coming years. According to the results of a 2019 study led by Divyang Patel, MD, Cleveland Clinic, some 300,000 patients a year are receiving new CIED implants – making RM even more complex and challenging for clinicians. In her 2022 study, Challenges in managing a remote monitoring device, Margaret Harvey, Ph.D., ACNP-BC, uncovered major themes plaguing the efficiency of RM in the cardiac clinic, such as poor connectivity, staffing issues, and a large volume of false positive alerts.Medical staff is drowning in an onslaught of data that cripples staff productivity and efficiency. But with every challenge comes opportunity. Dr. Harvey says the industry must adapt and develop innovative solutions that move healthcare forward. Luckily, digital health solutions already exist that can help ease the burden of RM data processing. Implicity offers a fully integrated SaaS solution that automates remote workflows, easing the burden on already overworked clinical staff. For example, the Implicity platform recently received FDA approval on an exclusive AI algorithm that automatically reduces the number of ILR false positives by 79% *. False positives from ILRs aren’t mere annoyances; they burden medical teams with so much extra work that it can effectively reduce the number of patients a clinic can support. Using an AI algorithm to reduce the “noise” of ILR alerts reduces the time clinicians and staff must dedicate to taxing data analysis. Also worth mentioning is Implicity’s disconnected patient feature. The platform auto-notifies the patients’ medical team when they become disconnected from the manufacturer’s website. A series of automated SMS messages are exchanged between the platform and the patient to obtain and record the reason for the disconnection, all without involvement from the clinical staff. Managing this process automatically ensures patient records are always up to date, have greater billing accuracy, and have higher staff productivity. There are many choices regarding remote monitoring software, but they are not all created equal. Clinics should look for a partner that easily integrates with their EHR and all the device manufacturer websites to streamline their process. Keeping future growth in mind, look for AI platforms to ensure continued access to relevant, robust data. By:Megan Grosz Download PDF

Contributed Article, Press

What’s in Store for Biotech in 2023?

/

What’s in Store for Biotech in 2023? Electrophysiologist Arnaud Rosier, CEO, and Co-Founder at Implicity, sits down with LABIOTECH to discuss AI’s expanding role in Cardiology “In 2023, we will see the first large-scale use of AI algorithms in healthcare. Several factors, including the speed of innovation, are driving this surge. AI algorithms are improving, making models more accurate and reliable. More and more healthcare organizations will start utilizing artificial intelligence across clinical and non-clinical domains. “Another force driving AI adoption is the clinician burnout epidemic. Covid-19 stretched an already thin healthcare staff nearly to their breaking point, and the “Great Resignation” that followed has made it difficult for clinics and hospitals to find and retain talent. Technology, specifically artificial intelligence, may become a viable solution for many providers to help reduce workloads and alleviate stress by eliminating routine, mundane tasks.” Visit LABIOTECH for the full article

Contributed Article, Press

AI for Electrophysiology: Cutting through the noise

/

AI for Electrophysiology: Cutting through the noise The use of AI in electrophysiology is increasing; it’s being applied to personalize treatment to achieve better outcomes, to manage patients more effectively, and it’s relieving the burdensome workflow of a data-intensive clinical practice. Electrophysiology is among the most data-driven of medical specialties, perhaps because these cardiac physicians chronically deal with the risk of imminent death. On the intervention side, when performing cardiac ablations, they work with highly technical patterns of electrical signals in real-time to figure out the source of problems so they can fix them. When it comes to patient management, they face an ever-increasing burden of daily downloads of data from cardiac implantable electronic devices (CIEDs), including pacemakers, ICDs (implantable cardioverter defibrillators), cardiac rhythm therapies, and implantable loop recorders (ILRs). In the US, where cardiac arrhythmias impact about 14.4 million patients, CIEDs have become the prevalent treatment choice. More than 300,00 people are implanted with cardiac monitoring devices every year, and this number is likely to increase because of the increasing prevalence of atrial fibrillation. Visit MedTech Strategist for the full articleBy Arnaud Rosier, CEO of ImplicityOriginally published by MedTech Strategist

Contributed Article, Press

Weeding Out False Positives from ILRs

/

Weeding Out False Positives from ILRs Healthcare providers are swamped with false alarms from remote patient monitoring systems. Here’s how AI can help solve the problem. Remote patient monitoring systems have made enormous inroads in healthcare in recent years, especially for chronically ill patient populations. The ability to passively monitor patients for adverse events and warning signs can save lives, but it also creates substantial logistical hurdles for healthcare providers– especially cardiologists, electrophysiologists, and their support staff. In particular, we’re seeing increased adoption of implantable loop recorders (ILRs) which are implanted underneath the skin of a patient’s chest and then used to detect abnormal rhythms that can be warning signs for stroke. Such devices are now connected and able to transmit data to the ‘cloud’ in order to be reviewed by healthcare professionals. Obviously, the data from these devices must be remotely monitored for alerts. ILRs are designed to be extremely sensitive so that they don’t miss any critical events, but this sensitivity often leads to an unwieldy number of false positives – which can quickly overwhelm healthcare teams. Read the full article on Medhealth Outlook website. By Arnaud Rosier, CEO of Implicity

Contributed Article, Press

Preventing Clinician Burnout with AI

/

Preventing Clinician Burnout with AI Burnout among doctors and nurses was already a major problem facing healthcare organizations, even before the COVID pandemic – maybe even more for healthcare professionals working in the extremely demanding field of cardiology. It’s not just a matter of long hours and overwhelming patient loads (although these factors certainly don’t help). Burnout is also the result of the pressure that healthcare providers put on themselves to be perfect when the stakes are literally a matter of life or death. According to one recent survey, 43 percent of cardiologists report feeling burnt out, compared to 39 percent in academic medicine and 32 percent of nurses. Those numbers are alarmingly high, but healthcare organizations often lack good options for addressing the problem. The COVID-19 pandemic stretched already thin healthcare staff nearly to their breaking point, and the ensuing “Great Resignation” has made it difficult for clinics and hospitals to recruit and retain new talent. Even if a healthcare organization is able to find prospects, budget limitations often prevent them from expanding their staff enough to meaningfully reduce burnout. Technology (in particular, artificial intelligence) may become a viable solution for many healthcare organizations. Here are four ways that AI can prevent and reduce burnout for clinicians. Read the full article in Electronic Health Reporter Magazine. By Arnaud Rosier, CEO of IMPLICITY®.

Contributed Article, Press

Why AI Is Becoming a Must-Have for Remote Patient Monitoring

/

Why AI Is Becoming a Must-Have for Remote Patient Monitoring Remote patient monitoring solutions are producing more patient data each year. The only way for healthcare providers to process it all – and support their patients – is with artificial intelligence-based tools. Once a technology enters our lives, it becomes impossible to imagine living without it. The first smartphones only hit the market around 15 years ago, for instance, and it feels like we’ve had them forever. Widespread streaming of digital media is even younger, and yet most of us barely remember how to operate our dust-covered DVD players. We’re about to hit a similar technology tipping point when it comes to artificial intelligence in healthcare. And providers need to be ready for a near-future where AI is essentially mandatory – especially for remote patient monitoring programs. Implicity’s AI algorithm that analyzes ECG data from implantable loop recorders (ILRs) only received clearance from the Food and Drug Administration late last year, and already we’re seeing it become a mission-critical technology for some of our customers. Here are four use cases that will soon make AI solutions in healthcare impossible to ignore. Read the full article on AITechPark.     By Arnaud Rosier, CEO of IMPLICITY®.

Press, Press Release

Implicity to Participate in Health Tech Challengers Super Finals at the HLTH 2022

/

Implicity to Participate in Health Tech Challengers Super Finals at the HLTH 2022 Company named a Top 8 Super Finalist in the global health tech competition identifying the most disruptive companies shaping the future of digital health. Cambridge, Mass., November 8, 2022 – Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022. The global competition identifies top companies fostering digital health innovation. Implicity won the Cardiovascular track and is one of only eight startups invited to pitch in-person at the live event in Las Vegas on November 15, 2pm at Venetian Ballroom D, Lvl 2, where the ultimate winner will be announced. “We’re honored to be among such an impressive group of finalists. This recognition validates the positive impact our AI-powered platform is having on cardiologists and healthcare professionals who care for patients with CIEDs. These remote cardiac monitoring solutions are producing more and more data each year. The only way for clinicians to process it all is with artificial intelligence-based tools. We are proud to deliver a solution to the market that can improve day-to-day life for practitioners, and allow them to spend more time with their patients,” said Dr. Arnaud Rosier, electrophysiologist, CEO, and co-founder of Implicity. Implicity’s AI algorithm that analyzes ECG data from implantable loop recorders (ILRs) received clearance from the Food and Drug Administration in late 2021. Earlier this year, the company announced $23M in Series A funding to accelerate expansion in the US and support the development of next-generation offerings that move toward the prevention of heart disease. Health Tech Challenger finalists were selected by a distinguished panel of industry experts from leading corporations, Venture Capital, ecosystem builders, and media partners. For more on the competition, visit: ​​https://healthtechchallengers.com/#TOP8   About Implicity Implicity® is a MedTech software company, cofounded by cardiac electrophysiologist Arnaud Rosier MD, that provides a universal cardiac remote monitoring and research platform to clinics and service companies – helping them provide the best remote care to cardiac patients. Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, which reduce the workload on healthcare professionals. The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers and improves care for patients with chronic heart failure conditions. Implicity proudly protects more than 70,000 patients in 150+ medical facilities across the United States and Europe.     Media Contact: Samantha Choinski eMedia Junction  860-301-5058 samantha@emediajunction.com

Press

AiThority Interview with Dr. Arnaud Rosier

/

AiThority Interview with Dr. Arnaud Rosier Dr. Arnaud Rosier, the co-founder of the health tech company Implicity, provides a window into how artificial intelligence impacts his field. Hi, please tell us about your journey in AI technology and how you started with Implicity. I founded Implicity about six years ago to solve some of the workflow challenges I faced as a Cardiac Electrophysiologist. My Ph.D. is in health informatics, and I wanted to develop a tool that would enable the adoption of remote cardiac patient monitoring. So, we developed a cloud-based platform leveraging machine learning and AI-based algorithms to aggregate data from various cardiac implantable electronic devices (CIEDs) and manage the entire clinical and administrative workflow. This allows cardiologists, electrophysiologists, and their teams to scale remote patient care and optimize revenues. Today, Implicity covers more than 70,000 patients in 100 medical facilities across the United States and Europe. In addition, the platform is used by clinical and academic researchers. Investigators can use intelligent cardiac remote care and research solution to support their studies. Read the full interview by AiThority – AI Technology Insights

Press

Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders

/

Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders Industry veterans Vanessa Joyce named VP of Sales for North America and Megan Grosz appointed Head of Global Marketing and Communications   Cambridge, Mass., September 28th, 2022 – Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company’s new Vice President of Sales for North America and Megan Grosz was appointed Global Head of Marketing and Communications. “We’re thrilled to welcome these two impressive leaders. Both Vanessa and Megan bring a wealth of industry knowledge to support our rapid global expansion, particularly in the U.S.  where we see a dramatic rise in remote patient monitoring,” said Dr. Arnaud Rosier- Electrophysiologist, CEO, and Co-founder of Implicity. Vanessa Joyce comes to Implicity with more than 30 years of experience in MedTech marketing and clinical aspects of the Cardiac, Heart Failure, and Electrophysiology industries. Prior to joining the Company, she served as the area director of sales for Rhythm Management Group. She also held sales leadership roles at Philips Healthcare, Medtronic, and St. Jude Medical. “I’m excited to apply my expertise and experience to establish Implicity as the primary CIED remote monitoring software solution,” said Joyce. “We are building an extraordinary sales force to bring this unparalleled technology to providers and revolutionize care for CIED patients. This solution will help drive the adoption of RPM by helping cardiologists, electrophysiologists, and their teams manage the growing volume of data and false alerts that are becoming so difficult and time-consuming to review.” To help communicate the unique benefits of Implicity’s automated cardiac remote monitoring platform, Megan Grosz is joining Implicity as Head of Global Marketing and Communications. She will leverage her sales and business development success to drive increased brand awareness and reach for Implicity with an emphasis on the recently FDA-approved AI algorithm that analyzes ECG episodes from Implantable Loop Recorders (ILRs). According to a study published in the European Heart Journal, applying the machine learning algorithm to ECG data collected by Medtronic’s ICMs decreased the false positive rate by nearly 80%. Grosz previously served as the Director of Sales and Marketing at Omega Medical Imaging, a manufacturer of AI-enabled, image-guided interventional imaging systems for cardiology, electrophysiology, interventional radiology, and therapeutic endoscopy. “There is a growing appetite for intelligent, cloud-based solutions that can improve the productivity and efficiency of care delivery. By handling data-intensive tasks and reducing false positive alerts, Implicity’s AI-powered platform can make a real difference in the lives of healthcare providers. All of this translates into better outcomes for patients,” said Grosz. “I look forward to sharing this unique solution with providers around the world.”   ————————— About IMPLICITY® Implicity® is a digital MedTech company, – founded by cardiac electrophysiologist Arnaud Rosier MD – that provides a universal cardiac remote monitoring and research platform to clinics and service companies- helping them provide the best remote care to cardiac patients. Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, which reduce the workload on healthcare professionals. The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers – and improves care for patients with chronic heart failure conditions. Implicity proudly protects more than 70,000 patients in more than 100 medical facilities across the United States and Europe.

The Smarter Way to Monitor Every Heart.

Request a Demo

Solutions

Platform

Clinical Evidence

About Us

News

Login

Research & Innovation

Others

Legal

©2026 – Implicity – All Rights Reserved